Brown Rudnick advised Aerovate Therapeutics Inc. on the deal. Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve...
Aerovate Therapeutics’ IPO
Graphite Bio’s $150-Million Series B Financing
Brown Rudnick LLP advised the lead investors RA Capital Management and Rock Springs Capital Management on the deal. RA Capital Management and Rock Springs Capital Management...